BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12356584)

  • 1. Association of genetic defects in primary resected lung adenocarcinoma revealed by targeted allelic imbalance analysis.
    Cave-Riant F; Cuillerier B; Beau-Faller M; Martinet N; Alla F; Bronner C; Schneider A; Oudet P; Gaub MP
    Am J Respir Cell Mol Biol; 2002 Oct; 27(4):495-502. PubMed ID: 12356584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
    Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
    Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
    J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
    el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
    Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary adenocarcinomas of the lung in nonsmokers show a distinct pattern of allelic imbalance.
    Wong MP; Lam WK; Wang E; Chiu SW; Lam CL; Chung LP
    Cancer Res; 2002 Aug; 62(15):4464-8. PubMed ID: 12154056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients.
    Beau-Faller M; Gaub MP; Schneider A; Ducrocq X; Massard G; Gasser B; Chenard MP; Kessler R; Anker P; Stroun M; Weitzenblum E; Pauli G; Wihlm JM; Quoix E; Oudet P
    Int J Cancer; 2003 Jun; 105(3):361-70. PubMed ID: 12704670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma.
    Tomizawa Y; Adachi J; Kohno T; Hamada K; Saito R; Noguchi M; Matsuno Y; Hirohashi S; Yamaguchi N; Yokota J
    Clin Cancer Res; 1999 May; 5(5):1139-46. PubMed ID: 10353749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
    Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
    Zhou X; Kemp BL; Khuri FR; Liu D; Lee JJ; Wu W; Hong WK; Mao L
    Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma.
    Tomizawa Y; Kohno T; Kondo H; Otsuka A; Nishioka M; Niki T; Yamada T; Maeshima A; Yoshimura K; Saito R; Minna JD; Yokota J
    Clin Cancer Res; 2002 Jul; 8(7):2362-8. PubMed ID: 12114441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
    Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
    Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers.
    Sanchez-Cespedes M; Decker PA; Doffek KM; Esteller M; Westra WH; Alawi EA; Herman JG; Demeure MJ; Sidransky D; Ahrendt SA
    Cancer Res; 2001 Mar; 61(5):2092-6. PubMed ID: 11280771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic heterogeneity in lung and colorectal carcinoma as revealed by microsatellite analysis in plasma or tumor tissue DNA.
    Beau-Faller M; Weber JC; Schneider A; Guèrin E; Gasser B; Ducrocq X; Jaeck D; Wihlm JM; Quoix E; Gaub MP
    Cancer; 2003 May; 97(9):2308-17. PubMed ID: 12712488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits.
    Yen CC; Liang SC; Jong YJ; Chen YJ; Lin CH; Chen YM; Wu YC; Su WC; Huang CY; Tseng SW; Whang-Peng J
    Lung Cancer; 2007 Sep; 57(3):292-301. PubMed ID: 17553591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity in laryngeal cancer.
    Rogowski M; Walenczak I; Pepiński W; Skawrońska M; Sieśkiewicz A; Klatka J
    Rocz Akad Med Bialymst; 2004; 49():262-4. PubMed ID: 15631354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal and parallel evolution of primary lung cancers and their metastases revealed by molecular dissection of cancer cells.
    Takahashi K; Kohno T; Matsumoto S; Nakanishi Y; Arai Y; Yamamoto S; Fujiwara T; Tanaka N; Yokota J
    Clin Cancer Res; 2007 Jan; 13(1):111-20. PubMed ID: 17200345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allelic losses on chromosomes 1p, 3p, 11p, 11q in non small cell lung cancers].
    Cheng JQ; Crépin M; Hamelin R
    C R Acad Sci III; 1990; 311(5):175-9. PubMed ID: 2169974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions.
    Martinet N; Alla F; Farré G; Labib T; Drouot H; Vidili R; Picard E; Gaube MP; Le Faou D; Siat J; Borelly J; Vermylen P; Bazarbachi T; Vignaud JM; Martinet Y
    Cancer Res; 2000 Jun; 60(11):2869-75. PubMed ID: 10850430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q.
    Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M
    Genes Chromosomes Cancer; 2000 Mar; 27(3):244-51. PubMed ID: 10679913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.